Interventions to Reduce Anticholinergic Burden in Adults Aged 65 and Older: A Systematic Review

Older age is associated with multimorbidity and polypharmacy with high anticholinergic burden (ACB). High ACB is linked to adverse events such as poor physical functioning, dementia, cardiovascular disease, and falls. Interventions are needed to reduce this burden.